CLOV CLOVER HEALTH INVESTMENTS, CORP. /DEcompanySEC Filings & Insider Trading Activity 2026
Latest CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 27, 2026, a 10-Q quarterly report filed on November 7, 2025, an 8-K current report filed on April 1, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) (SEC CIK 1801170), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-09-30)
Risk Factors
- • No new or updated risk factors disclosed this quarter from 2024 Form 10-K risks
- • Regulatory risk: ongoing compliance with evolving healthcare laws and potential Medicaid/Medicare reimbursement changes
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 7.01: Regulation FD Disclosure
- • Clover Health published supplemental Q&A on Mar 6, 2026 addressing investor questions from Q4 2025 earnings
- • Content targets shareholder engagement beyond standard earnings disclosure — signal of active investor relations effort
Item 7.01: Regulation FD Disclosure
- • Clover Health published supplemental Q&A responses on March 6, 2026, addressing investor questions from Q4 2025 earnings
- • Full responses in Exhibit 99.1 and on IR website — key detail for investors seeking operational/financial color beyond the earnings release
Quarterly Reports Archive10-Q
AI-powered analysis of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) 10-Q quarterly reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) 8-K current reports disclosing material events.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 1, 2026 | — | — | — |
8-K | Mar 6, 2026 | — | Analysis | — |
8-K | Mar 6, 2026 | — | Analysis | — |
10-K | Feb 27, 2026 | Dec 31, 2025 | — | |
8-K | Feb 26, 2026 | — | Analysis | — |
8-K | Jan 14, 2026 | — | — | |
8-K | Dec 10, 2025 | — | — | |
10-Q | Nov 7, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Aug 8, 2025 | Jun 30, 2025 | — | |
10-Q | May 9, 2025 | Mar 31, 2025 | — | |
10-K | Mar 3, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 8, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 8, 2024 | Jun 30, 2024 | — | |
10-Q | May 7, 2024 | Mar 31, 2024 | — | |
10-K | Mar 14, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 6, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 8, 2023 | Jun 30, 2023 | — | |
10-Q | May 9, 2023 | Mar 31, 2023 | — | |
10-K | Mar 1, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 7, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 8, 2022 | Jun 30, 2022 | — | |
10-Q | May 9, 2022 | Mar 31, 2022 | — | |
10-K | Feb 28, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 9, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 11, 2021 | Jun 30, 2021 | — |
Frequently Asked Questions
What are the latest CLOV SEC filings in 2026?
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) has filed a 10-K annual report on February 27, 2026, a 10-Q quarterly report on November 7, 2025, an 8-K current report on April 1, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did CLOV file its most recent 10-K annual report?
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) filed its most recent 10-K annual report on February 27, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view CLOV 10-Q quarterly reports?
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)'s most recent 10-Q quarterly report was filed on November 7, 2025. SignalX displays every CLOV 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has CLOV filed recently?
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)'s most recent 8-K was filed on April 1, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find CLOV insider trading activity (Form 4)?
SignalX aggregates every CLOV Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does CLOV file with the SEC?
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new CLOV filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV).
What is CLOV's SEC CIK number?
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)'s SEC CIK (Central Index Key) number is 1801170. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1801170 to look up all CLOV filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find CLOV return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of CLOVER HEALTH INVESTMENTS, CORP. /DE SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 30+ filings.